About Us

Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com and social media channels. Contract Pharma offers a wide variety of products designed to maximize brand exposure and get your message across to the companies and decision makers that matter most. 

Reach more than 150,000 Industry Professionals on a monthly basis with integrated media packages across platforms

The pharmaceutical industry is undergoing rapid and transformative changes driven by technological advancements, shifting healthcare landscapes, and evolving patient demands. These trends are reshaping how drugs are developed, manufactured, distributed, and utilized, with a profound impact on both industry stakeholders and patients. In 2025, Contract Pharma invites you to join us as we explore some of the most significant pharmaceutical trends that are shaping the future of healthcare. 

Outsourcing Continues to Grow 

To help navigate the complexities of today’s evolving drug development and manufacturing landscape, pharmaceutical and biotechnology companies are increasingly relying on contract service providers for their expertise. Outsourcing continues to grow each year due to the cost savings, access to specialized knowledge, and flexibility that contract research organizations (CROs), contract manufacturing organizations (CMOs), and contract development and manufacturing organizations (CDMOs) provide. According to analysis conducted by Visiongain, the market for pharmaceutical and biopharmaceutical contract services was valued at $116 billion in 2021, grew to $145 billion in 2023, and is projected to reach more than $330 billion by 2032. 

*Google Analytics July 1, 2023 – June 30, 2024; + HubSpot Email Marketing platform ( July 2nd, 2024); 1 LinkedIn, X,, Facebook as of June 30, 2024, 2 PushEngage + OneSignal as of July 8, 2024 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters